Skip Navigation

Strengthen the Evidence for Maternal and Child Health Programs

Sign up for MCHalert eNewsletter

Search Results: MCHLine

Items in this list may be obtained from the sources cited. Contact information reflects the most current data about the source that has been provided to the MCH Digital Library.

Displaying records 1 through 5 (5 total).

Georgia Division of Public Health, Georgia Newborn Screening Program. 2004. Georgia newborn screening manual for metabolic diseases and hemoglobinopathies. Atlanta, GA: Georgia Newborn Screening Program, Georgia Division of Public Health, 54 pp.

Annotation: This report describes the Georgia Newborn Screening Program, a program requiring that every live born infant have a blood test for nine metabolic disorders (phenylketonuria, congenital hypothyroidism, maple syrup urine disease, galactosemia, tyrosinemia, homocystinuria, congenital adrenal hyperplasia, biotinidase deficiency, medium-chain acyl-CoA dehydrogenase deficiency) and for sickle cell disorders. The report provides an overview of the program; discusses its screening, testing and reporting, and diagnostic activities; and describes its follow-up programs. Education resources are also included.

Contact: Maternal and Child Health Library at Georgetown University, E-mail: [email protected] Web Site: https://www.mchlibrary.org Available from the website.

Keywords: Biotinidase deficiency, Blood tests, Congenital adrenal hyperplasia, Congenital hypothyroidism, Diagnosis, Galactosemia, Georgia, Homocystinuria, Maple syrup urine disease, Metabolic diseases, Neonatal screening, Newborn infants, Phenylketonuria, Resource materials, Sickle cell disease, State programs, Tyrosinemia

American Academy of Pediatrics. 2002. A compendium of resources on newborn screening policy and systems development. Elk Grove Village, IL: American Academy of Pediatrics, 61 pp.

Annotation: This compendium includes selected resources and abstracts on the following topics: (1) general newborn screening; (2) biotinidase deficiency, (2) congenital adrenal hyperplasia, (3) congenital hypothyroidism, (4) cystic fibrosis, (5) drug exposure, (6) galactosemia, (7) hearing screening, (8) hemoglobinapathies, (9) HIV, (10) medium chain co-A dehydrogenase deficiency, (11) phenylketonuria. Additional resources are provided on newborn screening policy; ethical, legal, and social issues; costs and financing of screening newborns; laboratory analysis; research and new technologies; and treatment and management. [Funded in part by the Maternal and Child Health Bureau]

Contact: National Resource Center for Patient/Family-Centered Medical Home, American Academy of Pediatrics, 345 Park Boulevard, Itasca, IL 60143, Telephone: (847) 434-7605 Secondary Telephone: (800) 433-9016, ext. 7605 Web Site: https://www.aap.org/en/practice-management/medical-home

Keywords: Biotinidase deficiency, Congenital adrenal hyperplasia, Congenital hypothyroidism, Cystic fibrosis, Drug affected infants, EPSDT, Ethics, Financing, Galactosemia, HIV, Hearing screening, Hemoglobinopathies, Laboratories, Legal issues, Management, Neonatal screening, Phenylketonuria, Research, Technology

Hofman LF, ed. 1992. Proceedings: 9th National Neonatal Screening Symposium—Newborn screening: A partner in preventing infant mortality. Washington, DC: Association of State and Territorial Public Health Laboratory Directors, 376 pp.

Annotation: These are the proceedings of the 9th National Neonatal Screening Symposium, held April 7-11, 1992 in Raleigh, North Carolina. The symposium brings together practitioners, laboratory specialists, program managers, and medical consultants with an interest in this field. The proceedings include abstracts from oral presentations and poster presentations; some of the major topics covered included federal regulations applicable to the newborn laboratory, the role of newborn screening in preventing sudden infant death syndrome, quality assurance, information systems, screening for hemoglobinopathies, and issues related to PKU and galactosemia.

Contact: Association of State and Territorial Public Health Laboratory Directors, 1211 Connecticut Avenue, N.W., Suite 608, Washington, DC 20036, Telephone: (202) 822-5227 Price unknown.

Keywords: Conference proceedings, Federal government, Galactosemia, Hemoglobinopathies, Neonatal screening, Phenylketonuria, Regulations, SIDS

Arthur Parmalee, Sr., Child Development Institute (7th: 1962: Los Angeles, California). 1964. The care of the retarded child: Therapy and prognosis—Proceedings. Washington, DC: U.S. Children's Bureau; for sale by U.S. Government Printing Office, 43 pp. (Children's Bureau publication; no. 417)

Annotation: These proceedings of an institute to inform physicians about the advances in the field of mental retardation discuss the problem of mental handicaps, diagnostic and therapeutic procedures for the treatment of neurosurgical problems in children, the role of the neurologist in the diagnosis of retardation, ophthalmologic problems, new developments in galactosemia, and the predictability Gesell development scales in Down's syndrome. [Funded by the Maternal and Child Health Bureau]

Contact: Maternal and Child Health Library at Georgetown University, E-mail: [email protected] Web Site: https://www.mchlibrary.org Available from the website.

Keywords: Children with developmental disabilities, Conferences, Diagnosis, Downs syndrome, Galactosemia, Mental retardation, Neurologists, Vision disorders

Guest, GM, Berry, H, Rubinstein, JH. 1962. Management of newborn siblings of patients with Phenylketonuria or Galactosemia . [Washington, D.C.]: Department of Health, Education, and Welfare, 15 pp.

Annotation: This research summary addresses the management of newborn siblings of patients with phenylketonuria (PKU) or galactosemia, both of which are associated with severe mental retardation if left untreated. The summary includes recommendations for the management of newborn infants who may have one of these hereditary metabolic disorders, and diagnostic procedures for newborn siblings born into families known to have PKU or galactosemia. Based on questionnaire responses from physicians in the U.S., Great Britain, Ireland, and Germany, the summary includes a table listing preventable forms of mental retardation and recommended treatment for each of the diseases.

Contact: HathiTrust Digital Library, University of Michigan, Telephone: (734) 764-8016 E-mail: [email protected] Web Site: https://www.hathitrust.org/digital_library Available from Hathitrust via participating libraries.

Keywords: Disease prevention, Galactosemia, Hereditary diseases, Mental retardation, Metabolic diseases, Phenylketonuria
   

The MCH Digital Library is one of six special collections at Geogetown University, the nation's oldest Jesuit institution of higher education. It is supported in part by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under award number U02MC31613, MCH Advanced Education Policy with an award of $700,000/year. The library is also supported through foundation and univerity funding. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government.